Last reviewed · How we verify

NCT05925725

Clinical Efficacy and Safety of Loxacon Dietary Supplement Capsules at Patients With Knee Arthrosis

Completed Phase 4 Last updated 15 November 2023
What this trial tests

Phase 4 trial testing • harpagozid • boswellin = LOXACON in Osteo Arthritis Knee in 100 participants. Completed in 6 September 2023.

Timeline
25 January 2023
Primary endpoint
5 May 2023
6 September 2023

Quick facts

Lead sponsorPolyclinic of the Hospitaller Brothers of St. John of God, Budapest
PhasePhase 4
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingquadruple
Primary purposehealth services research
Enrollment100
Start date25 January 2023
Primary completion5 May 2023
Estimated completion6 September 2023
Sites1 location across Hungary

Drugs / interventions tested

Conditions studied

Sponsor

Polyclinic of the Hospitaller Brothers of St. John of God, Budapest

Who can join

Adults 40 to 80, any sex, with Osteo Arthritis Knee. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study will be a multicenter, randomized, double-blind, follow-up clinical trial. Neither the examining doctor nor the patient knows which capsule they will receive. Just the test unlock the codes after completion. T

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Osteoarthritis: Insights into Diagnosis, Pathophysiology, Therapeutic Avenues, and the Potential of Natural Extracts.
    Coppola C, Greco M, Munir A, Musarò D, et al · · 2024 · cited 19× · PMID 38785519 · DOI 10.3390/cimb46050251

Verify or expand the search:

Other recruiting trials for Osteo Arthritis Knee

Currently open trials in the same condition.

Other Polyclinic of the Hospitaller Brothers of St. John of God, Budapest trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05925725.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing